TGF-β signaling is known to be involved in other diabetic complications, such as diabetic nephropathy and retinopathy35,36; thus, it is likely that this signaling pathway is a pathogenic factor of DN. This evidence concerns the gene TGFB1 and liver dysplastic nodule.